Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Baseline Dengue Serostatus Among Tetravalent Dengue Vaccine CYDTDV (Dengvaxia®) Recipients on Subsequent Virologically Confirmed Dengue in the Philippines

NCT03465254 is registered in ClinicalTrials.gov with University of the Philippines as lead sponsor.

NCT NCT03465254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03465254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Baseline Dengue Serostatus Among Tetravalent Dengue Vaccine CYDTDV (Dengvaxia®) Recipients on Subsequent Virologically Confirmed Dengue in the Philippines
Lead sponsor
University of the Philippines
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2016
Completion date
June 30, 2023
Enrollment
2,996 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dengue, dengue fever, severe dengue, virologically-confirmed dengue